Trial Details

Not recruiting
Basic Information
Clinical ID c2782
Identifier NCT03466983
Trial Title A Randomized, Double-blinded, Comparative Trial Comparing the Incidence of Hypophosphatemia in Relation to Repeated Treatment Courses of Iron Isomaltoside and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia Due to Inflammatory Bowel Disease
Trial URL Visit Original Page
Study Information
Study Results

No results available
Conditions IBD
Interventions Drug: Iron Isomaltoside;Drug: Ferric Carboxymaltose
Participant Information
Sponsor Pharmacosmos A/S
City -
Country/Region Denmark
Enrollment Criteria
Sex Requirement ALL
Age Requirement -
Study Design
Study Type Interventional
Phase PHASE4
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -